Hideki Takeda
Vermogen: 868 227 $ op 30-06-2026
Vermogen: 868 227 $ op 30-06-2026
Hideki Takeda is the founder of Scent Science International, Inc. He is currently an Independent Outside Director at Modalis Therapeutics Corp., a Representative Director at Medical Patent Research, Inc., an Outside Director at Ctex Co. Ltd., and a Director at Liid Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from Osaka University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PRISM BioLab Co., Ltd.
PRISM BioLab Co., Ltd. BiotechnologyHealth Technology Provides drug discovery and development services using proprietary platform technology 2,53% | 31-03-2026 | 935.000 ( 2,53% ) | 828 429 $ | 30-06-2026 |
| 31-12-2025 | 196.000 ( 0,2% ) | 39 798 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Directeur/Bestuurslid | 01-01-2016 |
Medical Patent Research, Inc. | Directeur/Bestuurslid | 01-01-2009 |
Ctex Co. Ltd. | Directeur/Bestuurslid | 01-02-2018 |
Scent Science International, Inc.
Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Oprichter | 23-07-2010 |
Liid Pharmaceuticals, Inc. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Osaka University
Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scent Science International, Inc.
Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Producer Manufacturing |
Modalis Therapeutics Corp.
Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Medical Patent Research, Inc. | |
Ctex Co. Ltd. | |
Liid Pharmaceuticals, Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau